Skip to content
FY'25FY'24FY'23FY'22
Returns
Return on equity-41.3%+13.5pp-54.7%-9.6pp-45.1%-9.1pp-36%-8.0pp
Return on assets-37.9%+10.7pp-48.6%-8.3pp-40.3%-7.7pp-32.7%-6.3pp
Return on invested capital-53%+17.7pp-70.7%-12.2pp-58.5%+22.3pp-80.8%
Liquidity
Current ratio14.1×+3.6×10.6×+0.2×10.4×-3.3×13.7×-2.2×
Quick ratio14.1×+3.6×10.6×+0.2×10.4×-3.3×13.7×-2.2×
Cash ratio2.2×-0.2×2.4×+1.2×1.1×-3.2×4.3×-10.6×
Leverage
Debt-to-equity0.0×0.0×0.0×0.1×0.0×
Debt-to-assets0.0×0.0×0.0×0.0×
Per Share
Book value per share$4.38+25.6%$3.49-19.9%$4.36-22.3%$5.61-22.0%
Valuation
Market capitalization$979.28M+23.4%$569.48M+7.7%$528.67M+123%$236.68M-59.2%
Enterprise value$926.18M+23.9%$519.43M+0.8%$515.5M+183%$181.94M-50.3%
Price / book2.4×-1.3×2.3×0.0×2.4×+1.3×1.1×-1.1×
Free cash flow yield-11.4%+3.3pp-20%-3.6pp-16.4%+16.3pp-32.6%-22.2pp
Earnings yield-13.8%+2.9pp-22.5%-3.4pp-19%+18.6pp-37.7%-24.1pp

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

Where do Oric Pharmaceuticals, Inc.'s ratios come from?
Every ratio is computed from Oric Pharmaceuticals, Inc.'s SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.